Jenny Link is a Dermatology physician affiliated with Mayo Clinic. OpenAlex indexes 41 publications with 5,598 citations (h-index 19). By OpenAlex citation count, this profile ranks in the top 10% of Dermatology profiles in the findmyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Sensory organs
30.8%Corticosteroid30.8%Hydrocortisone46%Clobetasol Propionate43%Betamethasone Diprop Augmented10%Part D<11 patientsAnti-infectives
28.1%Azole Antifungal13.4%Ketoconazole100%Part D≥40 patientsTetracycline-class Drug7.9%Doxycycline Hyclate51%Doxycycline Monohydrate49%Part D<11 patients+ 2 more classes in this area
Dermatology
19.3%Corticosteroid16.8%Triamcinolone Acetonide100%Part D≥54 patientsInterleukin-4 Receptor alpha Antagonist2.5%Dupixent Pen100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- 76534 Longitudinal 3D Total Body Photography Improves Detection of Earlier Stage and Thinner Melanomas: Novel Insights from a Tertiary-Center, Retrospective Analysis
Journal of the American Academy of Dermatology
2026 - Effectiveness of first generation disease-modifying therapy to prevent conversion to secondary progressive multiple sclerosis
Multiple Sclerosis and Related Disorders
2022
Similar KOLs
Other experts from the same institution or the same specialty.
S Rajkumar, MD
Mayo Clinic
Bradley Boeve, MD
Mayo Clinic
Rick Nishimura, MD
Mayo Clinic
Victor Montori, MD
Mayo Clinic
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”